Annual General Meeting Presentation Visuals
May 27, 2021
The presentation visuals from the Annual General Meeting of Imagion Biosystems are now available. Please click to view the presentation visuals at ASX.
Category: News
Presentation Visuals from 28th May 2021 Annual General Meeting
May 27, 2021
The presentation visuals from the 28th May 2021 Annual General Meeting are now available. Download here.
Chairman’s Address to the Annual General Meeting
May 27, 2021
The transcript of the chairman’s address to the Annual General Meeting of Shareholders, for the financial year ending December 2020, is now available. Please click
First Patient Enrolled in Phase I MagSense® HER2+ Breast Cancer Study
May 25, 2021
This week Imagion Biosystems has announced we have enrolled our first patient into our first clinical study. This is an important step for our Phase
Bob Proulx Speaks with The Market Herald
May 19, 2021
The Chairman and CEO of Imagion Biosystems, Bob Proulx, recently spoke with The Market Herald on a significant transaction in the molecular imaging market, and several
IBX Secures Additional Capital — Shareholders Exercise Options
May 10, 2021
Imagion Biosystems announced on 10 May 2021 that it has received a total of $44,545.32 for the exercise of options. The total was composed of
Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001
May 10, 2021
The document “Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001” was lodged with ASX on 10 May, 2021. Please click to review the
Imagion Biosystems and Patrys Limited to Collaborate on Brain Tumor Imaging
May 2, 2021
Imagion Biosystems is pleased to announce a partnership with the ASX-listed therapeutic antibody development company Patrys Limited. The collaborative research program aims to combine Imagion Biosystems
Quarterly Activity Report — Period ending 31 March 2021
April 29, 2021
Imagion Biosystems is pleased to report that we closed the first quarter of FY2021 maintaining a strong cash balance and having added a new study
Quarterly Activity Report for 31 March 2021 — Appendix 4C
April 29, 2021
Imagion Biosystems today released its Appendix 4C Quarterly Cashflow report and update on Company activities for the quarter ending 31 March 2021 (Q1 FY2021). Q1